BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20199875)

  • 1. Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.
    Dukkipati R; Kovesdy CP; Colman S; Budoff MJ; Nissenson AR; Sprague SM; Kopple JD; Kalantar-Zadeh K
    J Ren Nutr; 2010 Jul; 20(4):243-54. PubMed ID: 20199875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients.
    Feroze U; Molnar MZ; Dukkipati R; Kovesdy CP; Kalantar-Zadeh K
    J Ren Nutr; 2011 Jan; 21(1):100-4. PubMed ID: 21195929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.
    Rhee CM; Molnar MZ; Lau WL; Ravel V; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
    Perit Dial Int; 2014; 34(7):732-48. PubMed ID: 24385335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
    Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
    PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of age on survival predictability of bone turnover markers in hemodialysis patients.
    Lertdumrongluk P; Lau WL; Park J; Rhee CM; Kovesdy CP; Kalantar-Zadeh K
    Nephrol Dial Transplant; 2013 Oct; 28(10):2535-45. PubMed ID: 23904397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.
    Regidor DL; Kovesdy CP; Mehrotra R; Rambod M; Jing J; McAllister CJ; Van Wyck D; Kopple JD; Kalantar-Zadeh K
    J Am Soc Nephrol; 2008 Nov; 19(11):2193-203. PubMed ID: 18667733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients.
    Streja E; Wang HY; Lau WL; Molnar MZ; Kovesdy CP; Kalantar-Zadeh K; Park J
    Bone; 2014 Apr; 61():201-7. PubMed ID: 24486956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
    Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of low serum parathyroid hormone with protein-energy wasting in maintenance hemodialysis patients].
    Su FX; Wu J; Zhou CM; Li Q; Hu SS; Lin X; Da JJ; Zha Y
    Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(42):3401-3405. PubMed ID: 30440133
    [No Abstract]   [Full Text] [Related]  

  • 10. Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients.
    Shinaberger CS; Kopple JD; Kovesdy CP; McAllister CJ; van Wyck D; Greenland S; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1769-76. PubMed ID: 18701614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients.
    Shantouf R; Kovesdy CP; Kim Y; Ahmadi N; Luna A; Luna C; Rambod M; Nissenson AR; Budoff MJ; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2009 Jun; 4(6):1106-14. PubMed ID: 19423565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation.
    Avram MM; Mittman N; Myint MM; Fein P
    Am J Kidney Dis; 2001 Dec; 38(6):1351-7. PubMed ID: 11728974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
    Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R
    Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine, vascular calcifications and parathyroid hormone serum levels in hemodialysis patients.
    Coen G; Mantella D; Sardella D; Beraldi MP; Ferrari I; Pierantozzi A; Lippi B; Di Giulio S
    J Nephrol; 2009; 22(5):616-22. PubMed ID: 19809994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
    Navarro JF; Mora C; Macia M; Garcia J
    Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis.
    Rambod M; Kovesdy CP; Bross R; Kopple JD; Kalantar-Zadeh K
    Am J Clin Nutr; 2008 Dec; 88(6):1485-94. PubMed ID: 19064507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
    Tomida K; Hamano T; Mikami S; Fujii N; Okada N; Matsui I; Nagasawa Y; Moriyama T; Ito T; Imai E; Isaka Y; Rakugi H
    Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients.
    Park JC; Kovesdy CP; Duong U; Streja E; Rambod M; Nissenson AR; Sprague SM; Kalantar-Zadeh K
    Hemodial Int; 2010 Apr; 14(2):182-92. PubMed ID: 20345388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
    Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Yamamoto S; Karaboyas A; Komaba H; Taniguchi M; Nomura T; Bieber BA; De Sequera P; Christensson A; Pisoni RL; Robinson BM; Fukagawa M
    BMC Nephrol; 2018 Oct; 19(1):253. PubMed ID: 30290781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.